E5 Pharma launches generic Proglyceme5 Pharma's diazoxide oral suspension is the first generic of Proglycem. Lupin gets FDA OK for generic DiproleneBetamethasone dipropionate ointment had a market value of roughly $22 million, according to IQVIA September 2019 data. Fresenius Kabi debuts generic Bentyl Fresenius Kabi's generic Bentyl is available in a 20 mg per 2 mL single-dose vial. Redmond & Greer to become Mockingbird Pharma Mockingbird Pharma will replace the name Redmond & Greer as of Jan. 1, 2020. House Appropriations Committee passes CREATES Act The CREATES Act would stop drugmakers from limiting access to brand and biologic drugs necessary for generic and biosimilar drug development. FDA gives Zydus Cadila's generic Belviq tentative approval Zydus Cadila's generic Belviq is used together with diet and exercise to treat obesity. Prasco launches authorized generic NuvaRing In partnership with Merck, Prasco is launching an authorized generic of NuvaRing. Amgen prevails in Epogen patent dispute with Hospira An appeals court has affirmed a lower court verdict that upholds $70 million in damages awarded in September 2017. Amneal to acquire majority interest in AvKARE With its acquisition of AvKARE, Amneal enters the federal healthcare market. Elite, SunGen get FDA nod for generic Adderall XR Adderall XR and its generics had a market value of $1.3 billion for the 12 months ended October 2019, according to IQVIA. First Previous 169 170 171 172 173 Next Last
